Erik Remaut

6.2k citations

37 papers · 5.0k indexed · 3 hit papers · h-index 22

Impact in

Biotechnology top 0.5%
Genetics top 1%
- Bacterial Genetics and Biotechnology
- Inflammatory Bowel Disease

Papers in

Genetics 24
- Bacterial Genetics and Biotechnology 17
- Inflammatory Bowel Disease 5
Endocrinology 4

Co-authors: Walter Fiers Lothar Steidler Patrick Stanssens Sabine Neirynck Wolfgang Hans Florian Obermeier Werner Falk Pieter Rottiers
Journals: Gene (6 papers)Gastroenterology (4 papers)Biotechnology and Bioengineering (2 papers)Nature Biotechnology (2 papers)Applied and Environmental Microbiology (2 papers)
Partner nations: Belgium United Kingdom Ireland

In The Last Decade

Erik Remaut

37 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease 2006 · 571 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Clinical Gastroenterology and Hepatology
2000 Science
1981 Gene

Peers

Countries citing papers authored by Erik Remaut

Since Specialization

Citations

This map shows the geographic impact of Erik Remaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Remaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Remaut more than expected).

Fields of papers citing papers by Erik Remaut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Remaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Remaut. The network helps show where Erik Remaut may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Remaut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Remaut Line = papers co-authored together Erik Remaut links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Commentary: Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge? PubMed ·Didier Breyer, Philippe Herman, Annick Brandenburger, Godelieve Gheysen, Erik Remaut, Patrice Soumillion, Jan Van Doorsselaere, René Custers, Katia Pauwels, Myriam Sneyers, Dirk Reheul	2009	27
2	A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease Clinical Gastroenterology and Hepatology ·Henri Braat, Pieter Rottiers, Daniël W. Hommes, Nathalie Huyghebaert, Erik Remaut, Jean‐Paul Remon, Sander J. H. van Deventer, Sabine Neirynck, Maikel P. Peppelenbosch, Lothar Steidler Hit paper breakdown →	2006	571
3	Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis Arthritis & Rheumatism ·Ken Coppieters, Torsten Dreier, Karen Silence, Hans de Haard, Marc Lauwereys, Peter Casteels, Els Beirnaert, Heidi Jonckheere, Christophe Van de Wiele, Ludovicus Staelens, Jeroen Hostens, Hilde Revets, Erik Remaut, Dirk Elewaut, Pieter Rottiers	2006	239
4	Improved periplasmic production of biologically active murine interleukin-2 in Escherichia coli through a single amino acid change at the cleavage site Process Biochemistry ·Johan Robbens, Wim De Coen, Walter Fiers, Erik Remaut	2006	6
5	Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice Gastroenterology ·Klaas Vandenbroucke, Wolfgang Hans, Jacques Van Huysse, Sabine Neirynck, Pieter Demetter, Erik Remaut, Pieter Rottiers, Lothar Steidler	2004	216
6	Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 Nature Biotechnology ·Lothar Steidler, Sabine Neirynck, Nathalie Huyghebaert, Veerle Snoeck, A. Vermeire, Bruno Goddeeris, Eric Cox, Jean Paul Remon, Erik Remaut	2003	405
7	Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement Gastroenterology ·Martine De Vos, Harald Peeters, S Sabato, Masykurotun Azzah, Debby Laukens, 陈有斌, Fr. Daems, Trianita Damayanti, Dirk Elewaut, Filip De Keyser, Claude Cuvelier, Eric Veys, Erik Remaut, Lothar Steidler, Herman Mielants	2003	1
8	A novel replication element from an Antarctic plasmid as a tool for the expression of proteins at low temperature Extremophiles ·Maria Luisa Tutino, Angela Duilio, Ermenegilda Parrilli, Erik Remaut, Giovanni Sannia, Gennaro Marino	2001	63
9	Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10 Science ·Lothar Steidler, Wolfgang Hans, GN Sharma, Sabine Neirynck, Florian Obermeier, Werner Falk, Walter Fiers, Erik Remaut Hit paper breakdown →	2000	1123
10	Increased Stability of Phage T7g10mRNA Is Mediated by either a 5’- or a 3’-Terminal Stem-Loop Structure Biological Chemistry Hoppe-Seyler ·友彦吉田, Erik Remaut, Walter Fiers	1996	15
11	Versatile, multi-featured plasmids for high-level expression of heterologous genes in Escherichia coli: overproduction of human and murine cytokines Gene ·Nico Mertens, Erik Remaut, Walter Fiers	1995	35
12	Simultaneous light emission from cloned Vibrio fischeri lux genes and expression of LamB or LamB–protein A fusion proteins in Escherichia coli depends on using a single chimeric operon Biotechnology and Bioengineering ·Lothar Steidler, Akihiko Kato, Erik Remaut	1995	1
13	Production in Escherichia coli of a functional murine and murine::human chimeric F(ab′)2 fragment and mature antibody directed against human placental alkaline phosphatase Journal of Biotechnology ·Daisy Flamez, Erik Remaut, Walter Fiers	1995	3
14	Efficient specific release of periplasmic proteins from Escherichia coli using temperature induction of cloned kil gene of pMB9 Biotechnology and Bioengineering ·Lothar Steidler, Walter Fiers, Erik Remaut	1994	10
15	Folding of the MS2 Coat Protein in Escherichia coli is Modulated by Translational Pauses Resulting from mRNA Secondary Structure and Codon Usage: A Hypothesis Journal of Theoretical Biology ·Cuzzio Andrade, Johan Robbens, Erik Remaut, Walter Fiers	1993	34
16	LamB as a carrier molecule for the functional exposition of IgG-binding domains of the Staphylococcus aureus Protein A at the surface of Escherichia coli K12 Molecular and General Genetics MGG ·Lothar Steidler, Erik Remaut, Walter Fiers	1993	21
17	[54] Use of phage lambda PL promoter for high-level expression of human interferons in Escherichia coli Methods in enzymology on CD-ROM/Methods in enzymology ·Erik Remaut, Patrick Stanssens, Guus Simons, Walter Fiers	1986	5
18	Functional expression of individual plasmid-coded RNA bacteriophage MS2 genes The EMBO Journal ·Erik Remaut, P. De Waele, Anne Marmenout, Patrick Stanssens, Walter Fiers	1982	33
19	The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·Walter Fiers, Erik Remaut, Fan Shu-lin, Hilde Cheroutre, Roland Contreras, Dirk Gheysen, Wim Degrave, Patrick Stanssens, Jan Tavernier, Yoichi Taya, (unknown)	1982	21
20	Expression of human fibroblast interferon gene in Escherichia coli Nature ·Erik De Clercq, Erik Remaut, SHAWNA M. HENRY, Patrick Stanssens, Jean Content, Walter Fiers	1980	152

About Erik Remaut

Erik Remaut is a scholar working on Genetics, Endocrinology, Ecology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 5.0k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (17 papers), Bacteriophages and microbial interactions (14 papers), RNA and protein synthesis mechanisms (13 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Inflammatory Bowel Disease (5 papers), Probiotics and Fermented Foods (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). The work is most often cited by research in Biotechnology (559 citations), Genetics (1.6k citations), Food Science (960 citations), Molecular Biology (3.0k citations) and Immunology (874 citations). Erik Remaut has collaborated with scholars based in Belgium, United Kingdom and Ireland. Frequent co-authors include Walter Fiers, Lothar Steidler, Patrick Stanssens, Sabine Neirynck, Walter Fiers, Wolfgang Hans, Florian Obermeier, Werner Falk, Pieter Rottiers and Nathalie Huyghebaert. Their work appears in journals such as Gene, Gastroenterology, Biotechnology and Bioengineering, Nature Biotechnology and Applied and Environmental Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact